Therefore, the alteration in the miRNA landscape by FhHDM-1, resultant activation of the PI3K/Akt pathway, and preservation of functional β-cell mass open therapeutic avenues for the prevention of T1D and T2D and treatment by enhancing islet transplantation outcomes. Here, AKT1 is linked to type 1 diabetes mellitus.